Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
36 studies found for:    "Precocious puberty"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed
Has Results
Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty
Conditions: Precocious;   Leuprolide Acetate;   Luteinizing Hormone (LH);   Gonadotrophin-releasing Hormone Agonist (GnRHa);   Tanner Staging;   Depot Formulation;   Suppression of LH;   Central Precocious Puberty (CPP);   Gonadotrophin-releasing Hormone (GnRH);   Lupron;   GnRH Analog;   Pediatrics Central Precocious Puberty
Intervention: Drug: Leuprolide Acetate 3 Month Depot
2 Completed Treatment of Boys With Precocious Puberty
Condition: Precocious Puberty
Interventions: Drug: Spironolactone;   Drug: Testolactone;   Drug: Deslorelin
3 Completed Histrelin Subcutaneous Implant in Children With Central Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Histrelin Subcutaneous Implant
4 Unknown  Follow-up of Girls With Premature Thelarche and Precocious Puberty
Conditions: Precocious Puberty;   Excess; Development, Breast
Intervention:
5 Completed Effects of Letrozole on Precocious Puberty Due to McCune Albright Syndrome
Conditions: McCune Albright Syndrome;   Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Letrozole
6 Unknown  First-Voided Urinary LH vs. GnRH-stimulation in Differentiating Slowly- From Rapidly Progressive-Precocious Puberty
Condition: Precocious Puberty, Gonadotropin-dependent
Interventions: Other: Measurement of LH in first-voided urine;   Other: collection of first-voided urine sample for LH level
7 Unknown  Markers of Pubertal Suppression During Therapy for Precocious Puberty
Condition: Central Precocious Puberty
Intervention:
8 Unknown  Analysis of Genetic and Environmental Parameters Influencing Growth Rate of Precocious Puberty Children
Condition: Central Precocious Puberty
Interventions: Drug: Triptorelin (GnRH agonists);   Drug: Leuprolide (GnRH agonists)
9 Unknown  Comparative Validation of the Triptorelin Test for the Diagnosis of CPP in Girls
Conditions: Central Precocious Puberty;   Sexual Precocity
Interventions: Drug: Triptorelin acetate and Gonadorelin acetate;   Drug: Gonadorelin acetate and Triptorelin acetate
10 Completed Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty
Conditions: Polyostotic Fibrous Dysplasia;   Precocious Puberty
Intervention: Drug: Testolactone
11 Recruiting Clinical Trial of Experienced Chinese Herbal Formulas on Different Types of Precocious Puberty
Condition: Precocious Puberty
Interventions: Drug: ziyinxiehuo Granules;   Drug: zishenqinggan Granules
12 Completed
Has Results
Efficacy and Safety Study of Pamoate of Triptorelin in Children With Precocious Puberty
Condition: Precocious Puberty
Intervention: Drug: Triptorelin pamoate 11.25mg (Decapeptyl® SR)
13 Completed Effects of Triptorelin Pamoate in Children With Precocious Puberty - Follow up Study
Condition: Precocious Puberty
Intervention: Drug: Triptorelin (I.N.N.)
14 Completed Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty
Condition: Central Precocious Puberty
Interventions: Drug: Triptorlin or Leuprorelin;   Drug: Zhibo dihuang pills;   Drug: Dabu ying pills
15 Recruiting Pharmacokinetic Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty
Condition: Precocious Puberty, Central
Intervention: Drug: Leuprolide Acetate 45 mg
16 Recruiting Pharmacokinetic Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Leuprolide
17 Completed
Has Results
Efficacy, Safety, and Pharmacokinetics (PK) of Triptorelin 6-month Formulation in Patients With Central Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Triptorelin
18 Completed The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty
Condition: Central Precocious Puberty
Intervention: Drug: Luphere depot 3.75mg(Leuprolide acetate 3.75mg)
19 Completed Purification of Testis-Stimulating Factor in Precocious Puberty
Condition: Precocious Puberty
Interventions: Drug: leuprolide;   Drug: testosterone
20 Completed Psychosocial Impact of Early Puberty in Girls Aged 6 to 8 Years
Condition: Early Puberty
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Indicates status has not been verified in more than two years